Pharmacology of movement Flashcards Preview

Neurology > Pharmacology of movement > Flashcards

Flashcards in Pharmacology of movement Deck (31)
Loading flashcards...
1
Q

What are Lewy bodies?

A

intracellular formations enriched in the protein alpha-synuclein

2
Q

What part of the brain is DaT imaging used on? In terms of Parkinson’s, what does this imaging show?

A

Looks at the striatum

Monitors the dopaminergic nigral cell loss

3
Q

List some of the features/symptoms of Parkinson’s disease.

A

Frozen facial expression
Flexed posture
Altered (shuffling) gait
Difficulting initiating + stopping movements
Gradual development of micrographia
Non motor features: olfactory dysfunction, depression, sleep disturbance, cognitive dysfunction

4
Q

What is the name of the scoring scale for disability that is commonly used for PD patients?

A

Schwaband England Activities of Daily Living
100% = independent, no slowness/impairment
0% = vegetative functions (swallowing, bladder + bowel) not functioning

5
Q

List some of the genes implicated in PD.

A
SNCA
LRRK2
GBA
PARK2 and PARK7
PINK1
6
Q

What is the result of defects in the SNCA gene?

A

it affects alpha-synuclein
it is a rare defect
duplications or triplications can cause autosomal dominant, familial PD

7
Q

What does MPTP stand for?

A

Methyl-phenyl-tetrahydropyridine

8
Q

What converts MPTP to MPP and why is this dangerous?

A

Monoamine oxidase B converts MPTP -> MPP (1-methyl-4-phenylpyridine)
This is dangerous as MPP is neurotoxic for dopaminergic neurones and can cause mitochondrial toxicity
Does this by inhibiting complex I in the mitochondrial respiratory chain - this reduces ATP production

9
Q

Name the 3 main dopaminergic pathways in the CNS.

A
  1. Mesocortical - ventral tegmental area –> prefrontal cortex
  2. Nigrostriatal - substantia nigra pars compacta –> dorsal striatum
  3. Mesolimbic - ventral tegmental area –> ventral striatum
10
Q

What type of receptors are dopamine receptors?

A

GPCRs

11
Q

What receptor subtypes belong to the D1 and D2 families respectively?

A

D1 family = D1, D5

D2 family = D2, D3, D4

12
Q

What is L-Dopa combined with peripherally and why?

A

DOPA decarboxylase inhibitors (Carbidopa and benserazide)
This prevents the conversion of L-Dopa to dopamine in the periphery (outside CNS)
This prevents adverse effects such as nausea and hypotension

13
Q

Give examples of dopamine agonists.

A
  • ropinirole
  • pramipexole
  • rotigotine
  • pergolide
  • bromocriptine
  • cabergoline
14
Q

What is the route of administration of rotigotine?

A

transdermal patch

15
Q

What is the route of administration of apomorphine?

A

infusion

16
Q

Why might a clinician prescribe MAOB inhibitors to a PD patient?

A

to preserve residual dopamine against oxidation

17
Q

Give two examples of MAOB inhibitors.

A

Rasagiline

Selegiline

18
Q

Why might a clinician prescribe anticholinergic/antimuscarininc compounds to a patient with PD?
Give examples of such compounds.

A

Dopamine loss can lead to hyperactivity in cholinergic cells

Examples = orphendarine, procyclidine, trihexyphenidyl

19
Q

Why might amantadine be an appropriate drug to prescribe to someone with PD?

A

it inhibits dopamine reuptake and increases dopamine release

20
Q

Give examples of motor complications associated with L-Dopa use.

A

“on-off” effect
“wearing off”/tolerance
dyskinesia, dystonia

21
Q

On what chromosome is the Huntingtin gene found?

A

Chromosome 4

22
Q

How is the Huntingtin gene mutated in Huntington’s disease?

A

gene presents with an abnormal number of repeats of glutamine (CAG codon)
An abnormal gene will contain >36 repeats leading to a GAIN of function (the mutated protein will aggregate inside of cells)

23
Q

What physical changes to the brain occur in Huntington’s?

A

Cortical atrophy
Striatal degeneration
Loss of medium size spiny neurones

24
Q

What are some of the mechanisms underlying neurodenegeration in Huntington’s?

A

Excitotoxicity (due to increases glutamate)
Loss of neurotrophic facotrs
Accumulation of aggregates of mutant huntingtin protein
Dysregulation of transcription
Increased oxidative stress
Abnormalities in axonal transport
Synaptic abnormalities

25
Q

List some of the symptoms of Huntington’s.

A
Choreic movement 
Gait abnormalities 
Lack of coordination 
Cognitive impairment 
Psychiatric disturbances 
Sleep disturbance 
Weight loss
26
Q

When might a COMT-inhibitor be prescribed for Parkinson’s? Give examples of these drugs.

A

Usually used in combination with L-dopa, so probably prescribed when L-dopa becomes less effective
Examples: tolcapone, entacapone

27
Q

Give examples of non-motor side effects of L-Dopa.

A
  • N+V
  • Postural hypotension
  • Psychosis
  • Impulse-control disorders
  • Excessive day time sleepiness
28
Q

What are the different surgical approaches to treating PD?

A
  • stimulation of subthalamic nucleus (DBS)

- pallidotomy/thalamotomy

29
Q

Give example(s) of vesicular amine transporters used to treat Huntington’s.

A

Tetrabenazine

30
Q

Give example(s) of antidopaminergic/antipsychotic drugs used to treat Huntington’s.

A

Haloperidol

Olanzapine

31
Q

Give example(s) of antidepressants used to treat Huntington’s.

A

Imipramine

Amitriptyline